This article written by Kirk Randall, Sales Director at Cryoport, will address particular issues surrounding the logistics and shipment of cryogenic animal health products such as these new regenerative therapies, as they represent the highest level of need for any organisation working with these products. They also represent a higher level of resource needs for the end user where the shippers often end up serving as temporary storage units for the veterinary clinics treating their livestock with these critical stem cell CONTENTS therapies for herd/flock health. The author will break the challenges into their core components and address solutions individually.